We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Medical and Surgical Abortion Are Equally Effective

By HospiMedica International staff writers
Posted on 21 Jun 2015
Print article
Virtually no difference exists between the effectiveness of medical and surgical abortions during the first trimester, according to a new study.

Researchers at the University of California Los Angeles (UCLA; USA; www.ucla.edu) conducted a retrospective cohort study comparing efficacy of medical and surgical abortion in 30,146 women who sought pregnancy termination before 64 days of gestation at Planned Parenthood (New York, NY, USA) clinics. Electronic medical records (EMRs) were reviewed for ongoing pregnancies after the initial abortion procedure. The researchers also collected data on complications occurring within the immediate period, such as unanticipated aspiration, perforation, hospitalization, transfusion, and infection.

The results showed that efficacy of pregnancy termination was 99.6% for medication abortions and 99.8% for surgical abortions. The medication abortion group, however, was more likely to undergo an unanticipated aspiration for ongoing pregnancy, persistent pain and bleeding, or both (2.1% compared with 0.6%). These rates were unchanged after controlling for gravidity, parity, and body mass index (BMI). There was no difference in major adverse events between the two groups. The study was published on June 5, 2015, in Obstetrics and Gynecology.

“Medication abortion and surgical abortion before 64 days of gestation are both highly effective with low complication rates,” concluded lead author Luu Doan Ireland, MD, MPH, and colleagues. “We wanted to explore whether different characteristics may impact the efficacy or safety of these abortion methods; patient age had an impact on both groups, increasing the risk by 3% with each year of patient age.”

Early first-trimester medical abortion regimens involve a 200 mg of oral mifepristone, followed 24–48 hours later by an 800 mcg dose of buccal misoprostol. This regimen, used by Planned Parenthood in the United States, is 98.3% effective through 59 days gestation. Mifepristone in combination with a prostaglandin analog (such as misoprostol) are also the most common methods used to induce second-trimester abortions in Canada, most of Europe, China, and India. In contrast, in the United States 96% of second-trimester abortions are performed surgically by dilation and evacuation.

Related Links:

University of California Los Angeles
Planned Parenthood


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Workstation
X40

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.